BioSpace News Archive

Policy

BrainScope Receives $4.5 Million Department of Defense Contract to Add Ocular Assessment to Future Concussion Products

BrainScope today announced that it has been awarded a research contract by the United States Department of Defense (DOD) valued at $4.5 million to create and integrate ocular capabilities into its handheld, multi-parameter mild Traumatic Brain Injury (mTBI) and concussion products.

September 4, 2018
·
4 min read
BiondVax to Present at Influenza 2018 Oxford Conference

BiondVax Pharmaceuticals Ltd. reported today it will present at the Influenza 2018 Oxford conference at the University of Oxford.

September 4, 2018
·
3 min read
Mallinckrodt To Present At Cantor Global Healthcare Conference

Mallinckrodt Pharmaceuticals will present on Tuesday, Oct. 2, 2018, at the Cantor Global Healthcare Conference at the InterContinental New York Barclay, 111 E. 48th St., New York.

September 4, 2018
·
2 min read
Biotech Beach

Dr. Craig Ziering Brings The Future Of Hair Restoration To All Patients

Practice Augments Treatment Portfolio With SmartGraft® For Minimally Invasive Hair Restoration Technology

September 4, 2018
·
3 min read
FDA

FDA Grants Priority Review to Merck’s Supplemental Biologics License Application for KEYTRUDA® (pembrolizumab) for the Treatment of Merkel Cell Carcinoma, a Rare Form of Skin Cancer

Application Based on Data from Phase 2 KEYNOTE-017 Trial

September 4, 2018
·
26 min read
Check-Cap Announces Promising Interim Results from its Ongoing Post-CE Approval Study of C-Scan® System Version 3

Management to present a corporate overview at the 20th Annual Rodman & Renshaw Global Investment Conference on Wednesday, September 5 at 3:00pm ET

September 4, 2018
·
7 min read
Business

Aquestive Therapeutics Reports Second Quarter 2018 Financial Results and Recent Business Highlights, Including Tentative Approval for Sympazan™

Aquestive Therapeutics is a specialty pharmaceutical company focused on identifying, developing and commercializing differentiated products to address unmet medical needs.

September 4, 2018
·
18 min read
Deals

Correvio Highlights Completion of SteadyMed Acquisition by United Therapeutics

Correvio Pharma Corp. today highlighted that United Therapeutics (NASDAQ: UTHR) has completed its acquisition of SteadyMed Ltd., Correvio’s partner and the licensor of Trevyent®.

September 4, 2018
·
7 min read
Lone Star Bio

HeartSciences Named Among ‘50 Smartest Companies of the Year 2018’ by The Silicon Review Magazine

Silicon Review, a leading Business and Technology magazine has named HeartSciences, as one of the 50 Smartest Companies of the Year 2018.

September 4, 2018
·
2 min read
Deals

Transcat Acquires Angel’s Instrumentation Inc.

Acquisition expands geographic presence to Virginia and broadens industrial on-site calibration capabilities

September 4, 2018
·
4 min read